United Therapeutics director converts 650 RSUs

UNITED THERAPEUTICS Corp director Ray Kurzweil reported the vesting and exercise of 650 restricted stock units into an equal number of shares of common stock on July 9, 2026.

Accepted by SEC EDGAR 07/13/2026 - 04:36 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

UNITED THERAPEUTICS Corp director Ray Kurzweil reported the vesting and exercise of 650 restricted stock units into an equal number of shares of common stock on July 9, 2026. The RSUs converted on a one-for-one basis with no exercise price. Following the transaction, Kurzweil holds 13,320 shares of common stock directly.

Insider Trade Summary

650 shares exercised/converted

Exercise 2 txns

Insider KURZWEIL RAY

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F2	650	$0.00	$0.00
Exercise	Common Stock F1	650	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 13,320 shares (Direct)

Footnotes (2)

1. F1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.
2. F2. Not applicable as restricted stock units do not have an expiration date.

Key Figures

RSUs converted: 650 shares Exercise price: $0.0000 per share Shares held after transaction: 13,320 shares

3 metrics

RSUs converted 650 shares Restricted stock units converted one-for-one into common stock on July 9, 2026

Exercise price $0.0000 per share Conversion price for restricted stock units into common stock

Shares held after transaction 13,320 shares Ray Kurzweil’s direct common stock holdings following the RSU conversion

Key Terms

Restricted Stock Units, derivative security, vesting

3 terms

Restricted Stock Units financial

"Shares received upon vesting of restricted stock units on July 9, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vesting financial

"Shares received upon vesting of restricted stock units on July 9, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ray Kurzweil report in this Form 4 for UTHR?

Ray Kurzweil reported the vesting and conversion of 650 restricted stock units into 650 shares of UNITED THERAPEUTICS Corp common stock on July 9, 2026, with no exercise price.

How many UTHR shares did Ray Kurzweil acquire in this transaction?

Ray Kurzweil acquired 650 shares of UNITED THERAPEUTICS Corp common stock through the vesting of restricted stock units converting on a one-for-one basis into common shares.

What is Ray Kurzweil’s UTHR shareholding after this Form 4 event?

After the reported transaction, Ray Kurzweil directly holds 13,320 shares of UNITED THERAPEUTICS Corp common stock, as disclosed in the post-transaction ownership figure.

Was there a cash exercise price for the UTHR restricted stock units?

No cash exercise price applied. The restricted stock units converted at $0.0000 per share, meaning the RSUs vested and automatically became common shares without a purchase payment.

What type of derivative security did Ray Kurzweil convert at UTHR?

Ray Kurzweil converted restricted stock units, classified as a derivative security, into 650 shares of UNITED THERAPEUTICS Corp common stock on a one-for-one basis upon vesting.

Do the UTHR restricted stock units reported have an expiration date?

The filing notes that an expiration date is not applicable because the restricted stock units do not have an expiration date; they converted into common stock upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KURZWEIL RAY

(Last) (First) (Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING MARYLAND 20910

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/09/2026		M(1)		650	A	$0.00(1)	13,320	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00(1)	07/09/2026		M(1)			650	07/09/2026	(2)	Common Stock	650	$0.00(1)	0.00	D

Explanation of Responses:

1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.

2. Not applicable as restricted stock units do not have an expiration date.

Remarks:

	/s/ John S. Hess, Jr. under Power of Attorney	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)